| Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study B Hajarizadeh, J Grebely, M Byrne, P Marks, J Amin, H McManus, T Butler, ... The lancet Gastroenterology & hepatology 6 (7), 533-546, 2021 | 64 | 2021 |
| Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐and post‐universal access to direct‐acting antiviral treatment in … S Bajis, J Grebely, B Hajarizadeh, T Applegate, AD Marshall, ... Journal of viral hepatitis 27 (3), 281-293, 2020 | 49 | 2020 |
| Prevalence of hepatitis C among Australian Aboriginal and Torres Strait Islander people: a systematic review and meta-analysis S Graham, ME Harrod, J Iversen, JS Hocking Hepatitis monthly 16 (7), 2016 | 25 | 2016 |
| Antivirals in the management of an influenza pandemic ME Harrod, S Emery, DE Dwyer Medical journal of Australia 185 (S10), S58-S61, 2006 | 22 | 2006 |
| Correlates of higher‐risk drug‐related behaviours at music festivals in New South Wales, Australia A Healey, KJ Siefried, ME Harrod, E Franklin, A Peacock, MJ Barratt, ... Drug and Alcohol Review 41 (2), 320-329, 2022 | 20 | 2022 |
| Designing, implementing and evaluating the overdose response with take‐home naloxone model of care: An evaluation of client outcomes and perspectives N Lintzeris, LA Monds, M Bravo, P Read, ME Harrod, R Gilliver, W Wood, ... Drug and alcohol review 39 (1), 55-65, 2020 | 19 | 2020 |
| Hepatitis C virus reinfection following direct-acting antiviral treatment in the prison setting: the SToP-C study JM Carson, GJ Dore, AR Lloyd, J Grebely, M Byrne, E Cunningham, ... Clinical Infectious Diseases 75 (10), 1809-1819, 2022 | 16 | 2022 |
| Central venous access and handwashing: variability in policies and practices. R Galway, ME Harrod, J Crisp, R Donnellan, J Hardy, A Harvey, ... Paediatric Nursing 15 (10), 14-19, 2003 | 16 | 2003 |
| Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and … J Grebely, R Gilliver, T McNaughton, A Conway, E Cunningham, ... International Journal of Drug Policy 114, 103982, 2023 | 15 | 2023 |
| Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019–2020 J Brett, KJ Siefried, A Healey, ME Harrod, E Franklin, MJ Barratt, J Masters, ... Clinical Toxicology 60 (4), 440-445, 2022 | 15 | 2022 |
| Physiological responses in high-P subjects during active and passive coping HC Beh, ME Harrod International journal of psychophysiology 28 (3), 291-300, 1998 | 15 | 1998 |
| Handwashing practice and policy variability when caring for central venous catheters in paediatric intensive care ML Morritt, ME Harrod, J Crisp, A Senner, R Galway, S Petty, L Maurice, ... Australian Critical Care 19 (1), 15-21, 2006 | 14 | 2006 |
| The role of specialist nurses in improving treatment adherence in children with a chronic illness ME Harrod, J Crisp, M Goode, S Wales Australian Journal of Advanced Nursing, The 21 (4), 2004 | 11 | 2004 |
| Point-of-care HCV RNA testing, linkage to nursing care, and peer-supported engagement and delivery to enhance HCV treatment among people with recent injecting drug use at a … J Grebely, R Gilliver, T McNaughton, C Henderson, B Hadlow, K Molloy, ... Proceedings of the International Conference on Hepatitis Care in Substance …, 2021 | 10 | 2021 |
| Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study A Conway, H Valerio, A Peacock, L Degenhardt, J Hayllar, ME Harrod, ... International Journal of Drug Policy 96, 103421, 2021 | 9 | 2021 |
| Care, agency and criminality: Making sense of authorised extended distribution in the accounts of key stakeholders J Bryant, L Brener, L Pepolim, ME Harrod International Journal of Drug Policy 71, 56-61, 2019 | 9 | 2019 |
| Patterns of peer distribution of injecting equipment at an authorized distribution site in Sydney, Australia L Brener, J Bryant, E Cama, L Pepolin, ME Harrod Substance Use & Misuse 53 (14), 2405-2412, 2018 | 9 | 2018 |
| Trends in hepatitis B prevalence and associated risk factors among Indigenous and non‐Indigenous prison entrants in Australia, 2004 to 2013 T Coles, P Simpson, D Saulo, J Kaldor, A Richards, M Levy, C Wake, ... Australian and New Zealand journal of public health 43 (3), 236-240, 2019 | 8 | 2019 |
| Awareness of HCV status and preferences for testing and treatment among people with recent injecting drug use at a peer-led needle and syringe program: the TEMPO pilot study A Conway, P Read, R Gilliver, T McNaughton, H Valerio, EB Cunningham, ... Viruses 14 (11), 2463, 2022 | 7 | 2022 |
| Barriers to help‐seeking among music festival attendees in New South Wales, Australia R Page, A Healey, KJ Siefried, ME Harrod, E Franklin, A Peacock, ... Drug and alcohol review 41 (6), 1322-1330, 2022 | 7 | 2022 |
Phillip ReadThe Kirby Institute, UNSWVerified email at sesiahs.health.nsw.gov.au
